Company Filing History:
6 out of 3,687 
1 out of 2 Years Active: 2014-2025
Title: The Innovative Contributions of Camilo Rojas
Introduction
Camilo Rojas is a prominent inventor based in Baltimore, MD, known for his significant contributions to the field of neurodegenerative diseases and cancer treatment. With a total of seven patents to his name, Rojas has made strides in developing small molecule inhibitors that target critical pathways in disease progression.
Latest Patents
Among his latest patents, Rojas has developed small molecule neutral sphingomyelinase 2 (nSMase2) inhibitors. These inhibitors are designed for treating neurodegenerative diseases associated with high levels of ceramide, including Alzheimer's disease, HIV-associated neurocognitive disorder, multiple sclerosis, and amyotrophic lateral sclerosis. Another notable patent includes 2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP), which serves as a small molecule inhibitor of nSMase2 for treating both neurodegenerative and oncologic diseases.
Career Highlights
Rojas has had a distinguished career, working with esteemed institutions such as The Johns Hopkins University and the Institute of Organic Chemistry & Biochemistry. His research has focused on innovative therapeutic approaches that address complex medical challenges.
Collaborations
Throughout his career, Rojas has collaborated with notable colleagues, including Barbara S. Slusher and Takashi Tsukamoto. These partnerships have enhanced his research and contributed to the advancement of his inventions.
Conclusion
Camilo Rojas continues to be a leading figure in the field of medical innovation, with his patents paving the way for new treatments for serious diseases. His work exemplifies the impact of dedicated research and collaboration in advancing healthcare solutions.